Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement

Journal of the American College of Cardiology

Volumn 35, Issue 5, 2000, Pages 1311-1316

  Hung, Judy ^a   Landzberg, Michael J ^b,c   Jenkins, Kathy J ^b   King, Mary Etta E ^a   Lock, James E ^b   Palacios, Igor F ^a   Lang, Peter ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; DEVICE; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTICENTER STUDY; NEUROLOGICAL COMPLICATION; PARADOXICAL EMBOLISM; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; BALLOON DILATATION; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LIFE TABLES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034083893     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00514-3     Document Type: Article

References (35)

1. Bogousslavsky J., Garazi S., Jeanrenaud X., Aebischer N., Van Melle G. Stroke recurrence in patients with patent foramen ovale the Lausanne study . Neurology. 46:1996;1301-1305.
2. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 318:1988;1148-1152.
3. Webster M.W.I., Chancellor A.M., Smith H.J., Swift D.L., Sharpe D.N., Bass N.M. Patent foramen ovale in young stroke patients. Lancet. 2:1988;11.
4. de Belder M.A., Tourikis L., Leech G., Camm J.A. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol. 69:1992;1316-1320.
5. DiTullo M., Sacco R.L., Gopal A., Mohr J.P., Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 117:1992;461-465.
6. Gaultier J.C., Durr A., Koussa S., Lascault G., Grosgogeat Y. Paradoxical cerebral embolism with a patent foramen ovale. Cerebrovasc Dis. 1:1991;193-202.
7. Ranoux D., Cohen A., Cabanes L., Amarenco P., Bousser M.G., Mas J.L. Patent foramen ovale is stroke due to paradoxical embolism? Stroke. 24:1993;31-34.
8. Homma S., DiTullo M.R., Sacco R.L., Smith C., Mohr J.P. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 28:1997;2376-2381.
9. Silverman M. Paradoxical embolus. N Engl J Med. 329:1993;930.
10. Hargreaves M., Maloney D., Gribbin B., Westaby S. Impending paradoxical embolism a case report and literature review . Eur Heart J. 15:1994;1284-1285.
11. Teague S.M., Sharma M.K. Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke. 22:1991;740-745.
12. Hust M.H., Staiger M., Braun B. Migration of paradoxic embolus through a patent foramen ovale diagnosed by echocardiography successful thrombolysis . Am Heart J. 129:1995;620-622.
13. Kristensen B., Malm J., Carlberg B., et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke. 28:1997;1702-1709.
14. Bogousslavsky J., Devuyst G., Nendaz M., Yamamoto H., Sarasin F. Prevention of stroke recurrence with presumed paradoxical embolism. J Neurol. 244:1997;71-75.
15. Nendaz M., Sarasin F., Bogousslavsky J. How to prevent stroke recurrence in patients with patent foramen ovale anticoagulants, antiaggregants, foramen closure, or nothing? Eur J Neurol. 37:1997;199-204.
16. Malthieu R., Sarasin F., Junod A.F., Bogousslavsky J. Preventing stroke recurrence in patients with patent foramen ovale antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective . Am Heart J. 135:1998;532-541.
17. Guffi M., Bogousslavsky J., Jeanrenaud X., Devuyst G., Sadeghi H. Surgical prophylaxis of recurrent stroke in patients with patent foramen ovale a pilot study . J Thorac Cardiovasc Surg. 112:1996;260-263.
18. Ruchat P., Bogousslavsky J., Hurni M., Fischer A.P., Jeanrenaud X., von Segesser L.K. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism early results of a preliminary study . Eur J Cardiothorac Surg. 11:1997;824-827.
19. Bridges N.D., Hellenbrand W., Latson L., Filiano J., Newburger J.W., Lock J.E. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 86:1992;1902-1908.
20. Ende D.J., Chopra P.S., Rao P.S. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism. Am J Cardiol. 78:1996;233-236.
21. Sideris E.B., Sideris S.E., Foulkes J.P., Smith J.E., Guilde R.A. Transvenous atrial septal defect occlusion in piglets using a 'buttoned' double disk device. Circulation. 82:1990;312-318.
22. Lock J.E., Rome J.J., Davis R., et al. Transcatheter closure of atrial septal defects experimental studies . Circulation. 79:1989;1091-1099.
23. Magni G., Hijazi Z.M., Pandian N.G., et al. Two- and three-dimensional transesophageal echocardiography in patient selection and assessment of atrial septal defect closure by the new DAS-Angel Wings device initial clinical experience . Circulation. 96:1997;1722-1728.
24. Rome J.J., Keane J.F., Perry S.B., Spevak P.J., Lock J.E. Double-umbrella closure of atrial defects initial clinical applications . Circulation. 82:1990;751-758.
25. Rao P.S., Wilson A.D., Chopra P.S. Transcatheter closure of atrial septal defect by 'Buttoned' Devices. Am J Cardiol. 69:1992;1056-1061.
26. Mehan V.K., Sideris E.B., Meier B. Use of the reversed button device to treat an atrial septal aneurysm associated with a patent foramen ovale. Br Heart J. 74:1995;563-565.
27. Prieto L.R., Foreman C.K., Cheatham J.P., Latson L.A. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella. Am J Cardiol. 77:1996;1310-1312.
28. Jenkins KJ, Gavreau K, Dwyer ME, Satou NL, Bates TA, Lock JE. Use of the CardioSEAL Device to close complex cardiac defects in high risk patients during catheterization. Circulation 1997;96 Suppl:I568.
29. Zahn EM, Benson LN, Hellenbrand W, et al. Transcatheter closure of secundum ASDs with the CardioSEAL septal occlusion system: early results of the North American Trial. Circulation 1997;96 Suppl:I568.
30. Justo R.N., Nykanen D.G., Boutin C., McCrindle B.W., Freedom R.M., Benson L.N. Clinical impact of transcatheter closure of secundum atrial septal defects with the double umbrella device. Am J Cardiol. 77:1996;889-892.
31. Comess K.A., DeRook F.A., Beach K.W., Lytle N.J., Golby A.J., Albers G.W. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia prevalence of findings and recurrent stroke . J Am Coll Cardiol. 23:1994;1598-1603.
32. Hanna J.P., Sun J.P., Furlan A.J., Stewart W.J., Sila C.A., Tan M. Patent foramen ovale and brain infarct echocardiographic predictors, recurrence, and prevention . Stroke. 25:1994;782-786.
33. Sharma A.K., Ofili E., Castello R., Sullivan N., Labovitz A.J. Effect of treatment on recurrent embolic events with atrial septal aneurysm and associated right to left shunting. J Am Soc Echocardiogr. 43:1991;294.
34. Mas J.L., Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J. 130:1995;1083-1088.
35. Cabanes L., Mas J.L., Cohen A. Atrial septal aneurysm and PFO as risk factors for cryptogenic stroke in patients less than 55 years of age. Stroke. 24:1993;1865-1873.